[HTML][HTML] A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection
AJ Hickey, L Gounder, MYS Moosa, PK Drain - BMC infectious diseases, 2015 - Springer
AJ Hickey, L Gounder, MYS Moosa, PK Drain
BMC infectious diseases, 2015•SpringerBackground Mycobacterium tuberculosis (TB) infection of the liver, known as hepatic TB, is
an extrapulmonary manifestation of TB. Hepatic TB has become more prevalent, likely as a
result of the human immunodeficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS) epidemic. We sought to review case series to characterize the epidemiology,
pathophysiology, clinical features, diagnosis, and treatment of hepatic TB and to comment
on the impact of HIV co-infection on these characteristics. Methods We conducted a …
an extrapulmonary manifestation of TB. Hepatic TB has become more prevalent, likely as a
result of the human immunodeficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS) epidemic. We sought to review case series to characterize the epidemiology,
pathophysiology, clinical features, diagnosis, and treatment of hepatic TB and to comment
on the impact of HIV co-infection on these characteristics. Methods We conducted a …
Background
Mycobacterium tuberculosis (TB) infection of the liver, known as hepatic TB, is an extrapulmonary manifestation of TB. Hepatic TB has become more prevalent, likely as a result of the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic. We sought to review case series to characterize the epidemiology, pathophysiology, clinical features, diagnosis, and treatment of hepatic TB and to comment on the impact of HIV co-infection on these characteristics.
Methods
We conducted a systematic literature search in PubMed and ScienceDirect for articles pertaining to hepatic TB with human subjects from 1960 to July 2013.
Results
We obtained data on 618 hepatic TB patients from 14 case series. The most common reported signs and symptoms were hepatomegaly (median: 80%, range: 10-100%), fever (median: 67%, range: 30–100), respiratory symptoms (median: 66%, range: 32-78%), abdominal pain (median: 59.5%, range: 40-83%), and weight loss (median: 57.5%, range: 20-100%). Common laboratory abnormalities were elevated alkaline phosphatase and gamma-glutamyl transferase. Ultrasound and computerized tomography (CT) were sensitive but non-specific. On liver biopsy, smear microscopy for acid-fast bacilli had a median sensitivity of 25% (range: 0-59%), histology of caseating granulomas had a median sensitivity of 68% (range: 14-100%), and polymerase chain reaction for TB had a median sensitivity of 86% (range: 30-100%). Standard anti-tuberculous chemotherapy for 6 to 12 months achieved positive outcomes for nearly all patients with drug-susceptible TB.
Conclusions
Clinicians in TB-endemic regions should maintain a high index of suspicion for hepatic TB in patients presenting with hepatomegaly, fever, respiratory symptoms, and elevated liver enzymes. The most sensitive imaging modality is a CT scan, while the most specific diagnostic modality is a liver biopsy with nucleic acid testing of liver tissue samples. Upon diagnosis, 4-drug anti-TB therapy should promptly be initiated. HIV co-infected patients may have more complex cases and should be closely monitored for complications.
Springer